Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer
ARMANI
1 other identifier
interventional
240
1 country
37
Brief Summary
the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 22, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 13, 2024
June 1, 2024
6.9 years
October 30, 2020
June 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Intrahepatic disease-free survival (iDFS)
Time from operation date to date of disease recurrence in the liver, followed up at intervals of three months for a maximum duration of 24 months or until death. Any new, solid lesion in the liver after resection of all CRLM that fulfils imaging criteria (CT, MRI) of a metastasis is counted as an iDFS event.
24 months
Secondary Outcomes (25)
Assessment of additional oncological and perioperative outcomes: Intraoperative blood loss [mL]
During surgery
Assessment of additional oncological and perioperative outcomes: Operating time [min]
During surgery
Assessment of additional oncological and perioperative outcomes: Transfusion of blood, transfused packed red blood cells (PRBC), fresh frozen plasma (FFP) and / or platelet concentrate (PC) [units]
48 hours after surgery
Assessment of additional oncological and perioperative outcomes: Duration of postoperative hospital stay [days]
At day of discharge, assessed up to 90 days
Assessment of additional oncological and perioperative outcomes: Duration of postoperative intermediate/intensive care unit stay [days]
At day of discharge, assessed up to 90 days
- +20 more secondary outcomes
Study Arms (2)
A - Anatomical resection
EXPERIMENTALremoval of the entire, tumor-bearing liver segment(s)
B - Non-anatomical resection
ACTIVE COMPARATORmetastasectomy with a margin of healthy liver tissue irrespective of segmental borders
Interventions
Comparison of two liver surgery methods
Eligibility Criteria
You may qualify if:
- Colorectal cancer with RAS mutation (KRAS or NRAS)
- Colorectal liver metastases (single or multiple)
- Planned R0 resection of liver metastases (and primary tumor, if present)
- Anatomical and non-anatomical liver resection technically feasible
- Male and female patients, age ≥ 18 years
- Written informed consent
You may not qualify if:
- Extrahepatic metastases
- Planned staged liver resection (e.g. two-stage hepatectomy)
- Diagnosis of another cancer \< 5 years prior to randomization Exceptions: curatively treated in situ cervical cancer, curatively resected non-melanoma skin cancer
- Expected lack of compliance
- Addiction or other illnesses which do not allow the person concerned to assess the nature and extent of the clinical trial and its possible consequences
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Technische Universität Dresdenlead
- German Cancer Research Centercollaborator
Study Sites (37)
Department of Surgery at the University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
Mannheim, Baden-Wurttemberg, 68167, Germany
Department of Gastrointestinal-, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden
Dresden, Saxony, 01307, Germany
Intestinal Center West Middle Franconia, ANregiomed Clinic Ansbach
Ansbach, Germany
Clinic for General, Vizeral and Transplant Surgery, Augsburg University Hospital
Augsburg, Germany
Department of General, Visceral and Vascular Surgery, Charité, University Medicine Berlin, Campus Benjamin Franklin Berlin
Berlin, Germany
Clinic and Polyclinic for General, Visceral, Thoracic and Vascular Surgery, University Hospital Bonn
Bonn, Germany
Surgical Clinic, Municipal Hospital Braunschweig gGmbH
Braunschweig, Germany
Cancer Center, Helios Amper-Hospital Dachau
Dachau, Germany
Surgical Clinic, Dortmund Hospital
Dortmund, Germany
Clinic for General and Visceral Surgery, Municipal Hospital Dresden
Dresden, Germany
Clinic for General, Visceral and Pediatric Surgery, University Hospital Düsseldorf
Düsseldorf, Germany
Surgical Clinic, University Hospital Erlangen
Erlangen, Germany
Clinic for General, Visceral and Transplant Surgery, University Hospital Frankfurt, Goethe University Frankfurt am Main
Frankfurt, Germany
Department for General and Visceral Surgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg
Freiburg im Breisgau, Germany
JLU Gießen, Department for General, Visceral, Thoracic and Transplant Surgery
Giessen, Germany
Clinic for General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Georg-August-University
Göttingen, Germany
Clinic and Polyclinic for General Surgery, Department of Gastrointestinal, Thoracic and Vascular Surgery, University Greifswald, University Hospital Greifswald
Greifswald, Germany
University Hospital and Polyclinic for Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale)
Halle, Germany
Center for Surgical Medicine - Clinic and Polyclinic for General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf
Hamburg, Germany
Department of Liver, Bile Duct and Pancreas Surgery, University Department of surgery, Asklepios Klinik Barmbek
Hamburg, Germany
Clinic for General, Visceral and Minimally Invasive Surgery, KRH Clinic Siloah, Hannover
Hanover, Germany
Medizinische Hochschule Hannover, Department of General, Visceral and Transplant Surgery
Hanover, Germany
Department of General, Visceral and Transplantation Surgery, University of Heidelberg
Heidelberg, Germany
General Visceral and Vascular Surgery, Jena University Medical Center
Jena, Germany
Clinic for Surgery, University Hospital Schleswig-Holstein Lübeck Campus
Lübeck, Germany
University Department of General, Visceral, Vascular and Transplant Surgery, Faculty of Medicine, Otto von Guericke University Magdeburg
Magdeburg, Germany
Clinic for General, Visceral and Transplantation Surgery, University Medical Center of the Johannes Gutenberg-University Mainz
Mainz, Germany
Clinic for Visceral, Thoracic and Vascular Surgery, University Hospital Giessen and Marburg
Marburg, Germany
LMU Munich Hospital, Clinic for General, Visceral and Transplant Surgery
Munich, Germany
Department Hepato-Pancreato-Biliary Surgery, Barmherzige Brüder gGmbH of the Hospital Barmherzige Brüder Munich
München, Germany
Department of Surgery, University Hospital rechts der Isar
München, Germany
Clinic for General, Visceral and Transplant Surgery, University of Münster
Münster, Germany
University Hospital for General and Visceral Surgery, Oldenburg Hospital
Oldenburg, Germany
Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center
Tübingen, Germany
Clinic for General and Visceral Surgery, Ulm University Medical Center
Ulm, Germany
General and Visceral Surgery, Helios University Medical Center Wuppertal, University Witten/Herdecke
Wuppertal, Germany
Department for General, Visceral, Transplant, Vascular and Pediatric Surgery, Julius-Maximilian-University Würzburg, University Hospital Würzburg
Würzburg, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Jürgen Weitz, Prof Dr med
Department of Gastrointestinal-, Thoracic and Vascular Surgery, University Hospital CGC
- PRINCIPAL INVESTIGATOR
Nuh Rahbari, Prof Dr med
Allgemein- und Viszeralchirugie, University Hospital Ulm
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2020
First Posted
December 22, 2020
Study Start
January 1, 2021
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
June 13, 2024
Record last verified: 2024-06